Axsome Therapeutics Inc reports results for the quarter - Earnings Summary

Axsome Therapeutics

12/11/2024 15:36

* Axsome Therapeutics Inc  AXSM.OQ  reported a quarterly
adjusted
loss of $1.34​​ per share for the quarter , lower than the same
quarter last year, when the company reported EPS of $-1.32.  The
mean expectation of seventeen analysts for the quarter was for a
loss of $1.41 per share. Wall Street expected results to range
from $-1.70 to -78 cents per share.
    * Revenue rose 81.3% to $104.76 million from a year ago;
analysts
expected $98.10 million. 
    * Axsome Therapeutics Inc's reported EPS for the quarter was
a
loss of $1.34​.
    * The company reported a quarterly loss of $64.6 million.
    * Axsome Therapeutics Inc shares had risen by 1.2% this
quarter and gained 14.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 7.6%
in the last three months.​ 
    * In the last 30 days, four analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 17 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Axsome
Therapeutics Inc is 117.50 
This summary was machine generated from LSEG data November 12 at
03:36 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.41          -1.34          Beat
 Jun. 30 2024      -1.33          -1.67          Missed
 Mar. 31 2024      -1.20          -1.44          Missed
 Dec. 31 2023      -1.17          -2.08          Missed